February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for achieving rhas received the CE mark. Paradise is designed to treat patients with resistant hypertension (HTN), a major risk factor for cardiovascular disease.

February 20, 2012 —Medtronic announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity drug-eluting stent (DES) for the treatment of coronary artery disease (CAD).

February 20, 2012 — U.S. Senate and House legislators have reached a “doc fix” agreement this week to prevent slashing payments to physicians treating Medicare patients. A law was to take effect at the beginning of March would have reduced reimbursements by 27 percent.

February 20, 2012 — Edwards Lifesciences Corp. announced that it received CE mark in Europe for its Edwards Intuity valve system for use in patients undergoing surgical aortic valve replacement (AVR).

February 20, 2012 — BG Medicine, Inc. announced positive results from its pivotal validation study for the CardioSCORE diagnostic test, previously known by the development name AMIPredict.

February 20, 2012 — Biopharmaceutical company Celladon Corp. this week completed a $43 million equity financing to advance its lead investigational drug candidate Mydicar for the treatment of heart failure.

February 20, 2012 — As part of president Obama’s pledge to reduce regulatory burden, Health and Human Services (HHS) secretary Kathleen Sebelius announced HHS will postpone the date at which certain health care entities have to comply with International Classification of Diseases, 10th Edition (ICD-10) diagnosis and procedure codes.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now